Literature DB >> 25389562

Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Peter M Mourani1, Marci K Sontag, Adel Younoszai, Joshua I Miller, John P Kinsella, Christopher D Baker, Brenda B Poindexter, David A Ingram, Steven H Abman.   

Abstract

RATIONALE: Pulmonary hypertension (PH) is associated with poor outcomes among preterm infants with bronchopulmonary dysplasia (BPD), but whether early signs of pulmonary vascular disease are associated with the subsequent development of BPD or PH at 36 weeks post-menstrual age (PMA) is unknown.
OBJECTIVES: To prospectively evaluate the relationship of early echocardiogram signs of pulmonary vascular disease in preterm infants to the subsequent development of BPD and late PH (at 36 wk PMA).
METHODS: Prospectively enrolled preterm infants with birthweights 500-1,250 g underwent echocardiogram evaluations at 7 days of age (early) and 36 weeks PMA (late). Clinical and echocardiographic data were analyzed to identify early risk factors for BPD and late PH.
MEASUREMENTS AND MAIN RESULTS: A total of 277 preterm infants completed echocardiogram and BPD assessments at 36 weeks PMA. The median gestational age at birth and birthweight of the infants were 27 weeks and 909 g, respectively. Early PH was identified in 42% of infants, and 14% were diagnosed with late PH. Early PH was a risk factor for increased BPD severity (relative risk, 1.12; 95% confidence interval, 1.03-1.23) and late PH (relative risk, 2.85; 95% confidence interval, 1.28-6.33). Infants with late PH had greater duration of oxygen therapy and increased mortality in the first year of life (P < 0.05).
CONCLUSIONS: Early pulmonary vascular disease is associated with the development of BPD and with late PH in preterm infants. Echocardiograms at 7 days of age may be a useful tool to identify infants at high risk for BPD and PH.

Entities:  

Keywords:  bronchopulmonary dysplasia; echocardiography; prematurity; pulmonary hypertension; pulmonary vascular disease

Mesh:

Year:  2015        PMID: 25389562      PMCID: PMC4299632          DOI: 10.1164/rccm.201409-1594OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  39 in total

1.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Pulmonary hypertension in infants with bronchopulmonary dysplasia.

Authors:  G Goodman; R M Perkin; N G Anas; D R Sperling; D A Hicks; M Rowen
Journal:  J Pediatr       Date:  1988-01       Impact factor: 4.406

4.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

5.  Growth of pulmonary microvasculature in ventilated preterm infants.

Authors:  Monique E De Paepe; Quanfu Mao; Jessica Powell; Sam E Rubin; Philip DeKoninck; Naomi Appel; Meredith Dixon; Füsun Gundogan
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

6.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

Authors:  M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

7.  Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease.

Authors:  A A Hislop; S G Haworth
Journal:  Pediatr Pulmonol       Date:  1990

8.  Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Hyo Soon An; Eun Jung Bae; Gi Beom Kim; Bo Sang Kwon; Jae Suk Beak; Ee Kyung Kim; Han Suk Kim; Jung-Hwan Choi; Chung Il Noh; Yong Soo Yun
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

9.  Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease.

Authors:  M A Rojas; A Gonzalez; E Bancalari; N Claure; C Poole; G Silva-Neto
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

10.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

View more
  129 in total

1.  Increased Cardiac Output and Preserved Gas Exchange Despite Decreased Alveolar Surface Area in Rats Exposed to Neonatal Hyperoxia and Adult Hypoxia.

Authors:  Kara N Goss; Robert S Tepper; Tim Lahm; Shawn K Ahlfeld
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

2.  More safety data: what about efficacy of sildenafil?

Authors:  K König
Journal:  J Perinatol       Date:  2016-02       Impact factor: 2.521

3.  Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.

Authors:  L B DeVries; R J Heyne; C Ramaciotti; L S Brown; M A Jaleel; V S Kapadia; P J Burchfield; L P Brion
Journal:  J Perinatol       Date:  2017-06-15       Impact factor: 2.521

4.  Retrospective Analysis of an Interdisciplinary Ventilator Care Program Intervention on Survival of Infants with Ventilator-Dependent Bronchopulmonary Dysplasia.

Authors:  Jason Gien; John Kinsella; Jodi Thrasher; Alicia Grenolds; Steven H Abman; Christopher D Baker
Journal:  Am J Perinatol       Date:  2016-06-29       Impact factor: 1.862

5.  Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age.

Authors:  Philip T Levy; Meghna D Patel; Swati Choudhry; Aaron Hamvas; Gautam K Singh
Journal:  J Pediatr       Date:  2018-04-03       Impact factor: 4.406

6.  Pulmonary hypertension in premature infants. Sharpening the tools of detection.

Authors:  Kathryn N Farrow; Robin H Steinhorn
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

7.  Pulmonary Microvascular Changes in Adult Survivors of Prematurity: Utility of Dynamic Contrast-enhanced Magnetic Resonance Imaging.

Authors:  Gregory P Barton; Luis A Torres; Kara N Goss; Marlowe W Eldridge; Sean B Fain
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

8.  Proteomic Profiles Associated with Early Echocardiogram Evidence of Pulmonary Vascular Disease in Preterm Infants.

Authors:  Brandie D Wagner; Ana E Babinec; Charlie Carpenter; Samantha Gonzalez; Grace O'Brien; Kara Rollock; Kayla Williamson; Peter M Mourani; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

9.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop.

Authors:  Rosemary D Higgins; Alan H Jobe; Marion Koso-Thomas; Eduardo Bancalari; Rose M Viscardi; Tina V Hartert; Rita M Ryan; Suhas G Kallapur; Robin H Steinhorn; Girija G Konduri; Stephanie D Davis; Bernard Thebaud; Ronald I Clyman; Joseph M Collaco; Camilia R Martin; Jason C Woods; Neil N Finer; Tonse N K Raju
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

10.  Maturational Patterns of Systolic Ventricular Deformation Mechanics by Two-Dimensional Speckle-Tracking Echocardiography in Preterm Infants over the First Year of Age.

Authors:  Philip T Levy; Afif El-Khuffash; Meghna D Patel; Colm R Breatnach; Adam T James; Aura A Sanchez; Cristina Abuchabe; Sarah R Rogal; Mark R Holland; Patrick J McNamara; Amish Jain; Orla Franklin; Luc Mertens; Aaron Hamvas; Gautam K Singh
Journal:  J Am Soc Echocardiogr       Date:  2017-04-19       Impact factor: 5.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.